Skip to main content
OpenTrials
Completed

NCT Number: NCT02586571

Growth and Body Composition in Breastfed Infants - Study on Age of Introduction of Complementary Foods in Iceland

The purpose of this prospective cohort study is to investigate breast-milk and breastfeeding among infants who are exclusively and partially breastfed at 6 months of age in terms of characteristics that are hypothesised to contribute to growth and development of body composition in infancy.

The scientific originality lies in the simultaneous sampling of multiple factors that are believed to contribute to growth and development of body composition in infancy, i.e. energy content of breast-milk, metabolism-regulating hormones in breast-milk, infant temperament and appetite. The selection of two predefined study groups, i.e. infants exclusively breastfed until 6 months of age and infants given complementary foods in addition to breast-milk from 3-4 months of age, gives the opportunity to describe, and perhaps up to some point compare, what now is described by the World Health Organization and in official Icelandic infant recommendations as "optimal feeding" and what studies have suggested is "common feeding" in many countries. The methods are carefully chosen, i.e. appropriate and non-invasive isotopes and validated questionnaires are used. To our knowledge, no study has reported breast-milk composition in exclusively vs. partially breastfed infants.

Completed

Looking for future studies?

Notify Me

Key information

About this study

At approximately 5 months of age, all infants in Iceland are invited to receive routine care (health checkup, immunization etc.) at the well-baby clinics at the primary health care centers in their neighbourhood. Nurses at well-baby clinics in and around Reykjavik cooperating with the study investigators screen all infants for eligibility according the eligibility criteria. Mothers of eligible infants receive oral and written information about the study and if interested, a written consent is obtained and study investigators are informed about the potential participant.

When the infant is around 5.5 months of age, the mother is contacted and a home visit by study investigators scheduled. In the home visit, more detailed information about the study is given and equipment for predose urine samples are given. The date for the first part of the study (day 0) is scheduled.

Day -1 and/or day 0: Mothers sample predose urine sample(s): 2x4 ml for group "Exclusive Breastfeeding A" and 1x2 ml for groups "Exclusive Breastfeeding B" and "Partial Breastfeeding".

Day 0 (home visit by investigators): Infant weighed, drinks 2.5 g/kg body weight + 1 g doubly labeled water or 0.7 g deuterium.

Mothers sample postdose urine samples: 6x4 ml for group "Exclusive Breastfeeding A" (days 1, 2, 3, 5, 6, 7) and 2x2 ml for the other groups (days 0+5 hours and day 2).

Mothers of infants in groups "Exclusive Breastfeeding B" and "Partial Breastfeeding" keep a 3-day weighed food record assessing their infants' diet including breast milk (by test weighing).

Day 7 (home visit by investigators): 2x10 ml breast milk samples (fore and hind milk) are obtained, questionnaires answered by mothers: background questionnaire, food frequency questionnaire on mother's habitual diet, the Baby Eating Behaviour Questionnaire (BEBQ) and the Infant Behaviour Questionnaire-Revised (IBQ-R).

At 9 months of age mothers keep a 3-day weighed food record assessing the infants' diet including breast milk if the infant is still breastfed (by test weighing).

At 12 months of age the primary outcome measure is assessed. Day -1 or day 0: Mothers sample predose urine sample: 1x2 ml. Day 0 (home visit by investigators): Infant weighed, drinks 1.2 g deuterium. Mothers sample postdose urine samples: 2x2 ml (days 0+5 hours and day 2). Mothers keep a 3-day weighed food record assessing their infants' diet including breast milk if the infant is still breastfed (by test weighing).

Mothers answer the Child Eating Behaviour Questionnaire (CEBQ).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Icelandic mother
  • Singleton birth
  • Gestational age 37-42 weeks
  • Birth weight >2500 g
  • Living in Iceland until 12 months of age
  • Only groups "Exclusive Breastfeeding A" and "Exclusive Breastfeeding B": Exclusively breastfed at 5.5 months of age (≤5 formula feedings and ≤5 water feedings since birth allowed)
  • Only group "Partial Breastfeeding": Receiving at least 100 g / 100 ml of complementary foods (formula or solids) at 5.5 months of age

Exclusion criteria

  • Diseases or defects likely to affect growth or body composition
  • Not breastfed at 5.5 months of age

Treatment and study plan

breastfeeding

Behavioral

Breastfeeding at 5.5 months of age (exclusive or partial)

Primary outcomes

  1. Total body water measured by deuterium oxide

    Time frame: 12 months of age of child

    Total body water measured by deuterium oxide and used to determine fat-free mass

Secondary outcomes

  1. Metabolisable energy content of breast milk measured using doubly labelled water

    Time frame: 5.5 months of age of child

    Measured using doubly labelled water (this outcome only measured in group labeled 'Exclusive Breastfeeding A')

  2. Weight measured by infant scales

    Time frame: 0-12 months of age of child

    Weight measured by infant scales

  3. Length measured by calibrated lengthboards

    Time frame: 0-12 months of age of child

    Length measured by calibrated lengthboards

Other outcomes

  1. Infant eating behavior assessed using Baby Eating Behaviour Questionnaire (BEBQ)

    Time frame: 5.5 months of age of child

    Assessed using Baby Eating Behaviour Questionnaire (BEBQ)

  2. Infant temperament assessed using the Infant Behaviour Questionnaire-Revised (IBQ-R)

    Time frame: 5.5 months of age of child

    Assessed using the Infant Behaviour Questionnaire-Revised (IBQ-R)

  3. Leptin in breast milk

    Time frame: 5.5 months of age of child

    The metabolism-regulating hormone leptin measured in fore and hind milk samples

  4. Ghrelin in breast milk

    Time frame: 5.5 months of age of child

    The metabolism-regulating hormone ghrelin measured in fore and hind milk samples

  5. Cortisol in breast milk

    Time frame: 5.5 months of age of child

    The metabolism-regulating hormone cortisol measured in fore and hind milk samples

  6. Infant eating behavior assessed using Child Eating Behaviour Questionnaire (CEBQ)

    Time frame: 12 months of age of child

    Assessed using Child Eating Behaviour Questionnaire (CEBQ)

Sponsors and collaborators

Lead sponsor

University of Iceland

Other

Collaborators

  • Harvard Medical School (HMS and HSDM)
  • Massachusetts General Hospital
  • University College, London

Registry information

Acronym: IceAge2

Important dates

Study start
2014
Primary completion
2019
Study completion
2019
First posted
Oct 26, 2015
Registry last updated
Nov 6, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.